Beyond 2D Cell Culture: How 3D Bioprinting Brings the Skeletal Microenvironment into the Lab

At Life Science Live, innovation in cell culture and microenvironment technologies takes center stage. One of the most forward-looking contributions to the program is the lecture “Beyond 2D Cell Culture: Emulating Skeletal Tissue Microenvironments through 3D Bioprinting” by Marco Domingos, PhD Associate Professor at the University of Manchester. His work demonstrates how the limitations of traditional 2D culture models can be overcome through advanced 3D biofabrication.

The limitations of 2D cell culture

Many biological processes are represented in an overly simplistic way in 2D systems. The absence of spatial structure, heterogeneity, and mechanical stimulation causes cells to behave differently than they do in vivo. As a result, these models have limited predictive value for tissue development, regeneration, and particularly drug research. Domingos emphasizes that it is not the cells themselves that are the limiting factor, but the environment in which they are placed.

3D bioprinting as a game changer

In his lecture, Domingos shows how 3D bioprinting can be used to recreate key features of the extracellular matrix (ECM). By designing bio-inks that mimic the composition and function of skeletal tissues – such as bone, cartilage, and meniscus – cells are provided with the appropriate biochemical and mechanical cues to follow their natural behavior. This results in models that more closely resemble key aspects of human tissue compared to conventional models.

From material design to functional tissue models

Domingos’ research does not focus solely on printing techniques, but also on the development of new biomaterials. By combining different biofabrication techniques, engineering-controlled architectures can be designed and fabricated, enabling 3D tissue models with defined structure and organization. These advanced structures are highly suitable for studying tissue behavior, regenerative processes, and disease mechanisms.

Impact on drug development and therapies

One of the most important advantages of these 3D models is their higher predictive value. Thanks to richer cell–matrix interactions, they generate data that correlates more closely with human responses. This makes them particularly relevant for drug screening, where greater reliability and reduced dependence on animal models are essential; for regenerative medicine, where biomaterials and implants can be assessed more effectively; and for disease modeling, offering a more realistic representation of pathological processes such as degenerative bone and cartilage disorders.

Bridging in vitro and in vivo

At Life Science Live, Domingos underscores that biofabrication represents more than technological progress alone: it is, above all, a catalyst for accelerating our understanding of human biology. By narrowing the gap between simplified in vitro models and complex in vivo biology, biofabrication enables more predictive and physiologically relevant platforms for regenerative medicine and drug development.

Interested in learning more? Join Life Science Live on May 19, Plus Ultra building Utrecht.